Financial Statements — KMDA
Balance Sheet
(in millions USD)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q3
2021 |
|---|
| Cash & Equivalents | 72.00 | 65.99 | 76.25 | 72.00 | 56.55 | 0.05 | 0.05 | 21.79 | 27.12 | 31.25 | 29.93 | 99.84 |
| Inventory | 85.41 | 82.08 | 78.36 | 71.56 | 78.71 | 0.08 | 0.07 | 80.24 | 79.75 | 73.03 | 64.52 | 48.16 |
| Total Current Assets | 192.73 | 183.27 | 188.50 | 164.41 | 166.43 | 0.16 | 0.15 | 129.68 | 131.40 | 135.16 | 118.60 | 178.94 |
| Goodwill | 30.31 | 30.31 | 30.31 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets | 184.48 | 184.90 | 186.61 | 186.80 | 184.61 | 0.19 | 0.18 | 184.71 | 185.39 | 184.48 | 185.53 | 37.58 |
| Total Assets | 377.21 | 368.17 | 375.11 | 351.21 | 351.04 | 0.34 | 0.34 | 314.39 | 316.80 | 319.64 | 304.14 | 216.53 |
| Total Current Liabilities | 47.84 | 45.77 | 57.05 | 34.00 | 40.90 | 0.04 | 0.04 | 65.83 | 69.28 | 69.15 | 49.68 | 26.59 |
| Total Non-current Liabilities | 64.14 | 62.45 | 66.10 | 61.94 | 58.99 | 0.06 | 0.06 | 71.81 | 72.71 | 77.94 | 82.88 | 8.32 |
| Total Liabilities* | 111.98 | 108.22 | 123.15 | 95.94 | 99.89 | 0.10 | 0.10 | 137.64 | 141.99 | 147.09 | 132.56 | 34.91 |
| Retained Earnings | (20.64) | (25.93) | (33.31) | (29.55) | (33.41) | (0.04) | (0.05) | (48.48) | (50.29) | (51.43) | (51.91) | (41.15) |
| Total Stockholder Equity | 265.23 | 259.95 | 251.96 | 255.27 | 251.15 | 0.25 | 0.24 | 176.75 | 174.81 | 172.55 | 171.57 | 181.61 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q3
2021 |
|---|
| Total Revenue | 47.01 | 44.75 | 44.02 | 41.74 | 42.47 | 0.04 | 0.04 | 37.44 | 30.71 | 32.22 | 23.59 | 23.03 |
| Cost of Revenue* | 27.25 | 25.83 | 23.27 | 24.51 | 23.52 | 0.02 | 0.02 | 23.01 | 18.87 | 19.35 | 16.35 | 17.30 |
| Gross Profit | 19.76 | 18.93 | 20.75 | 17.23 | 18.95 | 0.02 | 0.01 | 14.44 | 11.84 | 12.87 | 7.24 | 5.73 |
| Research & Development | 2.64 | 3.22 | 4.25 | 3.41 | 4.80 | 0.00 | 0.00 | 4.28 | 3.23 | 3.12 | 2.64 | 2.55 |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.31 | 2.69 |
| Total Operating Expenses* | 11.95 | 11.86 | 12.95 | 11.94 | 13.31 | 0.01 | 0.01 | 11.81 | 11.55 | 10.31 | 9.53 | 6.53 |
| Operating Income | 7.82 | 7.07 | 7.80 | 5.29 | 5.64 | 0.00 | 0.00 | 2.63 | 0.29 | 2.56 | (2.29) | (0.80) |
| Pretax Income | 6.37 | 5.75 | 6.61 | 3.95 | 4.49 | 0.00 | 0.00 | 1.91 | (1.80) | 0.49 | (3.91) | (0.84) |
| Tax Provision | 1.07 | (1.62) | 2.65 | -- | -- | -- | -- | 0.09 | 0.01 | 0.01 | 0.01 | 0.35 |
| Net Income | 5.30 | 7.38 | 3.96 | 3.86 | 4.43 | 0.00 | 0.00 | 1.81 | (1.81) | 0.48 | (3.92) | (0.84) |
| Basic EPS | 0.09 | 0.13 | 0.07 | 0.07 | 0.08 | 0.04 | 0.07 | 0.04 | (0.04) | 0.01 | (0.09) | (0.02) |
| Diluted EPS | 0.09 | 0.13 | 0.07 | 0.07 | 0.08 | 0.04 | 0.06 | 0.04 | (0.04) | 0.01 | (0.09) | (0.02) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q3
2021 |
|---|
| Operating Cash Flow | 10.42 | 8.02 | (0.51) | 22.21 | 13.96 | 0.00 | 0.00 | 1.82 | (2.85) | 5.49 | 10.89 | (2.67) |
| Investing Cash Flow | (3.59) | (2.01) | (1.46) | (2.12) | (3.01) | -0.00 | -0.00 | (1.05) | (1.09) | (1.62) | (0.68) | 34.59 |
| Financing Cash Flow | (0.75) | (16.12) | (0.29) | (4.79) | (2.68) | (0.01) | 0.03 | (5.85) | (2.88) | (2.26) | (2.40) | (0.32) |
